Tafluprost ethyl amide
Tafluprost ethyl amide is a prostaglandin derivative. Tafluprost ethyl amide is capable of reducing intraocular pressure (IOP) and influencing eyelash growth. Tafluprost ethyl amide can be used in antiglaucoma ophthalmic compositions[1].
Product Specifications
CAS Number
[1185851-52-8]
UNSPSC
12352005
Hazard Statement
H302, H360
Target
Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/tafluprost-ethyl-amide.html
Purity
99.56
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
FC(COC1=CC=CC=C1)(F)/C=C/[C@@H]2[C@H]([C@H](C[C@H]2O)O)C/C=C\CCCC(NCC)=O
Molecular Formula
C24H33F2NO4
Molecular Weight
437.52
Precautions
H302, H360
References & Citations
[1]Krupa M, et al. A Novel Convergent Synthesis of the Potent Antiglaucoma Agent Tafluprost. Molecules. 2017 Jan 31;22 (2) :217.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
Monoclonal RBBP9 Antibody (monoclonal) (M01), Clone: 2A11
Emodin, p56lck Tyrosine Kinase Inhibitor (1,3,8-Trihydroxy-6-Methylanthracene-9,10-Dione) discontinued. See 274767
Emodin, p56lck Tyrosine Kinase Inhibitor (1,3,8-Trihydroxy-6-Methylanthracene-9,10-Dione) discontinued. See 274767